Venture Certified
| 신기술기업(고도기술수반산업) | 2004-12-28 ~ 2006-12-27 | 041923032100115 | 2004-12-28 |
| 연구개발기업 | 2006-06-03 ~ 2008-06-02 | 061922021200067 | 2004-12-28 |
| 기술평가보증기업(기금) | 2008-06-03 ~ 2009-06-02 | 20080103110 | 2004-12-28 |
| 기술평가보증기업(기금) | 2010-03-16 ~ 2012-03-15 | 20100102119 | 2004-12-28 |
| 기술평가보증기업(기금) | 2012-03-16 ~ 2014-03-15 | 20120102432 | 2004-12-28 |
| 벤처투자유형 | 2014-03-16 ~ 2016-03-15 | 20140300107 | 2004-12-28 |
| 벤처투자유형 | 2016-03-16 ~ 2018-03-15 | 20160300230 | 2004-12-28 |
| 벤처투자유형 | 2018-03-16 ~ 2020-03-15 | 20180300255 | 2004-12-28 |
| 연구개발유형 | 2020-03-16 ~ 2022-03-15 | 20200400946 | 2004-12-28 |
| 연구개발유형 | 2022-03-16 ~ 2025-03-15 | 20220512020003 | 2004-12-28 |
| 연구개발유형 | 2025-03-16 ~ 2028-03-15 | 20250429020013 | 2004-12-28 |
Revenue CAGR +571.9%
| Item | 2023 | 2022 |
|---|---|---|
| Revenue | 336.6B | 50.1B |
| Operating Profit | -195.8B | -147.5B |
| Net Profit | -175.8B | -55.3B |
| Total Assets | 785.6B | 785.1B |
| Total Liabilities | 587.2B | 369.1B |
| Total Equity | 198.4B | 416.0B |
Operating Loss: Op. profit -196B
2 Consecutive Years of Net Loss
Debt Ratio Surge (+207pp YoY)
▲ 571.9%
▼ 32.8%
▲ 80.2%
▲ 233.7%
▼ 566.9%
| Name | Position | Role |
|---|---|---|
| 양길안 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기 성남시",
"ceo_name": "양길안",
"certificate": [
{
"cert_number": "041923032100115",
"changes": "",
"disclosure_date": "2004-12-28",
"first_cert_date": "2004-12-28",
"no": "1",
"type": "신기술기업(고도기술수반산업)",
"valid_period": "2004-12-28 ~ 2006-12-27"
},
{
"cert_number": "061922021200067",
"changes": "",
"disclosure_date": "2006-06-03",
"first_cert_date": "2004-12-28",
"no": "2",
"type": "연구개발기업",
"valid_period": "2006-06-03 ~ 2008-06-02"
},
{
"cert_number": "20080103110",
"changes": "",
"disclosure_date": "2008-05-21",
"first_cert_date": "2004-12-28",
"no": "3",
"type": "기술평가보증기업(기금)",
"valid_period": "2008-06-03 ~ 2009-06-02"
},
{
"cert_number": "20100102119",
"changes": "",
"disclosure_date": "2010-03-16",
"first_cert_date": "2004-12-28",
"no": "4",
"type": "기술평가보증기업(기금)",
"valid_period": "2010-03-16 ~ 2012-03-15"
},
{
"cert_number": "20120102432",
"changes": "",
"disclosure_date": "2012-03-23",
"first_cert_date": "2004-12-28",
"no": "5",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-03-16 ~ 2014-03-15"
},
{
"cert_number": "20140300107",
"changes": "",
"disclosure_date": "2014-03-27",
"first_cert_date": "2004-12-28",
"no": "6",
"type": "벤처투자유형",
"valid_period": "2014-03-16 ~ 2016-03-15"
},
{
"cert_number": "20160300230",
"changes": "",
"disclosure_date": "2016-05-04",
"first_cert_date": "2004-12-28",
"no": "7",
"type": "벤처투자유형",
"valid_period": "2016-03-16 ~ 2018-03-15"
},
{
"cert_number": "20180300255",
"changes": "",
"disclosure_date": "2018-04-12",
"first_cert_date": "2004-12-28",
"no": "8",
"type": "벤처투자유형",
"valid_period": "2018-03-16 ~ 2020-03-15"
},
{
"cert_number": "20200400946",
"changes": "",
"disclosure_date": "2020-05-11",
"first_cert_date": "2004-12-28",
"no": "9",
"type": "연구개발유형",
"valid_period": "2020-03-16 ~ 2022-03-15"
},
{
"cert_number": "20220512020003",
"changes": "",
"disclosure_date": "2022-05-12",
"first_cert_date": "2004-12-28",
"no": "10",
"type": "연구개발유형",
"valid_period": "2022-03-16 ~ 2025-03-15"
},
{
"cert_number": "20250429020013",
"changes": "",
"disclosure_date": "2025-04-29",
"first_cert_date": "2004-12-28",
"no": "11",
"type": "연구개발유형",
"valid_period": "2025-03-16 ~ 2028-03-15"
}
],
"company_name": "코아스템켐온 (주)",
"corp_no": "150111-*******",
"financials": {
"2022": {
"capital_stock": 16435188000,
"cost_of_sales": 3566469000,
"current_assets": 15851457000,
"current_liabilities": 26785732000,
"gross_profit": 1442671000,
"net_income": -5527129000,
"net_income_bs": -6256084000,
"non_current_assets": 62659866000,
"non_current_liabilities": 10121683000,
"non_operating_expenses": 7279888000,
"non_operating_income": 16499485000,
"operating_profit": -14746726000,
"revenue": 5009141000,
"sga_expenses": 16189398000,
"total_assets": 78511323000,
"total_equity": 41603909000,
"total_liabilities": 36907415000
},
"2023": {
"capital_stock": 16435188000,
"cost_of_sales": 30164466000,
"current_assets": 10080392000,
"current_liabilities": 41600536000,
"gross_profit": 3492690000,
"net_income": -17577001000,
"net_income_bs": -17572505000,
"non_current_assets": 68477076000,
"non_current_liabilities": 17119042000,
"non_operating_expenses": 6304179000,
"non_operating_income": 8304830000,
"operating_profit": -19577652000,
"revenue": 33657156000,
"sga_expenses": 23070342000,
"total_assets": 78557468000,
"total_equity": 19837890000,
"total_liabilities": 58719579000
}
},
"industry": "기초 의약 물질 제조업",
"investment": [
{
"amount": "4,045,040,000",
"changes": "4,045,040,000",
"date": "2013-08-16"
}
],
"main_products": "줄기세포치료제 제조",
"phone": "02-497-****",
"years": [
2023,
2022
]
}